Oscar Health Inc. (OSCR): Price and Financial Metrics


Oscar Health Inc. (OSCR): $6.24

0.34 (+5.76%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

OSCR Stock Price Chart Interactive Chart >

Price chart for OSCR

OSCR Price/Volume Stats

Current price $6.24 52-week high $18.89
Prev. close $5.90 52-week low $3.89
Day low $5.70 Volume 1,472,100
Day high $6.25 Avg. volume 1,800,640
50-day MA $4.90 Dividend yield N/A
200-day MA $7.93 Market Cap 1.32B

Oscar Health Inc. (OSCR) Company Bio


Oscar Health, Inc. is a holding company which provides health insurance services. The company was founded by Mario Tobias Schlosser, Kevin Nazemi and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.


OSCR Latest News Stream


Event/Time News Detail
Loading, please wait...

OSCR Latest Social Stream


Loading social stream, please wait...

View Full OSCR Social Stream

Latest OSCR News From Around the Web

Below are the latest news stories about Oscar Health Inc that investors may wish to consider to help them evaluate OSCR as an investment opportunity.

What 6 Analyst Ratings Have To Say About Oscar Health

Within the last quarter, Oscar Health (NYSE: OSCR ) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 3 2 0 1 Last 30D 0 1 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 2 1 0 0 3M Ago 0 0 0 0 1 In the last 3 months, 6 analysts have offered 12-month price targets for Oscar Health. The company has an average price target of $12.25 with a high of $20.00 and a low of $6.50. Below is a summary of how these 6 analysts rated Oscar Health over the past 3 months. The greater the number … Full story available on Benzinga.com

Benzinga | February 14, 2022

Orphazyme, Y-mAbs Therapeutics top healthcare gainers; ProQR, Senseonics lead losers pack

Gainers: Orphazyme ORPH +22%. Y-mAbs Therapeutics YMAB +11%. Oscar Health (OSCR) +9%. Theravance Biopharma TBPH +9%. VistaGen Therapeutics (VTGN) +8%.Losers: ProQR Therapeutics PRQR -72%

Seeking Alpha | February 11, 2022

Oscar Health, Inc. (OSCR) Q4 2021 Earnings Call Transcript

At this time, I would like to welcome everyone to Oscar Health's 2021 fourth quarter and full year earnings conference call. Thank you for joining us for our fourth quarter and year-end earnings call, where we'll discuss our financial results, the benefits of our increasing scale and reaffirm our 2022 outlook. Mario Schlosser, Oscar's co-founder and chief executive officer; and Scott Blackley, Oscar's chief financial officer, will host this afternoon's call, which can also be accessed through our investor relations website at ir.hioscar.com.

Yahoo | February 11, 2022

Oscar Health Announces Results for Fourth Quarter and Full Year 2021

NEW YORK--(BUSINESS WIRE)--Health insurtech company Oscar Health, Inc. (NYSE: OSCR) today announced its financial results for the fourth quarter and year ended December 31, 2021. We had a strong performance in Q421 and are pleased to have met or exceeded all of our expectations across key metrics, including Medical Loss Ratio and EBITDA said Mario Schlosser, CEO and Co-Founder of Oscar. Our historic growth during Open Enrollment signifies that our tech-enabled member-centric strategy and bra

Business Wire | February 10, 2022

Oscar Health shares jump postmarket on upbeat forecast

Oscar Health (OSCR) rises 6% aftermarket after it forecast premiums of $6.1B-6.4B in 2022, a Y/Y increase of ~80% at the midpoint.OSCR projects adj

Seeking Alpha | January 27, 2022

Read More 'OSCR' Stories Here

OSCR Price Returns

1-mo 25.55%
3-mo 1.63%
6-mo -4.59%
1-year -58.81%
3-year N/A
5-year N/A
YTD -20.51%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.43 seconds.